Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Hepatitis C

  Free Subscription


25.03.2019

1 Clin Res Hepatol Gastroenterol
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
1 J Hepatol
2 J Viral Hepat
1 PLoS Comput Biol
2 PLoS One
1 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Clin Res Hepatol Gastroenterol

  1. COSTA VD, Delvaux N, Brandao-Mello CE, Nunes EP, et al
    Prevalence of baseline NS3 resistance-associated substitutions (RASs) on treatment with protease inhibitors in patients infected with HCV genotype 1.
    Clin Res Hepatol Gastroenterol. 2019 Mar 14. pii: S2210-7401(19)30048.
    PubMed     Text format     Abstract available


    Eur J Gastroenterol Hepatol

  2. FOUAD R, Elsharkawy A, Abdel Alem S, El Kassas M, et al
    Clinical impact of serum alpha-fetoprotein and its relation on changes in liver fibrosis in hepatitis C virus patients receiving direct-acting antivirals.
    Eur J Gastroenterol Hepatol. 2019 Mar 20. doi: 10.1097/MEG.0000000000001400.
    PubMed     Text format     Abstract available


    Gastroenterology

  3. SINGAL AG, Lim JK, Kanwal F
    AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
    Gastroenterology. 2019 Mar 13. pii: S0016-5085(19)33558.
    PubMed     Text format    


    J Hepatol

  4. DENG L, Jiang W, Wang X, Merz A, et al
    Syntenin regulates Hepatitis C virus sensitivity to neutralizing antibody by promoting E2 secretion through exosomes.
    J Hepatol. 2019 Mar 14. pii: S0168-8278(19)30147.
    PubMed     Text format     Abstract available


    J Viral Hepat

  5. SIMMONS R, Ireland G, Ijaz S, Ramsay M, et al
    Causes of death among persons diagnosed with hepatitis C infection in the pre and post DAA era in England: a record linkage study.
    J Viral Hepat. 2019 Mar 21. doi: 10.1111/jvh.13096.
    PubMed     Text format     Abstract available

  6. DUCHESNE L, Lacombe K
    Innovative technologies for point-of-care testing of viral hepatitis in low-resource and decentralized settings.
    J Viral Hepat. 2017 Nov 13. doi: 10.1111/jvh.12827.
    PubMed     Text format     Abstract available


    PLoS Comput Biol

  7. KALEMERA M, Mincheva D, Grove J, Illingworth CJR, et al
    Building a mechanistic mathematical model of hepatitis C virus entry.
    PLoS Comput Biol. 2019;15:e1006905.
    PubMed     Text format     Abstract available


    PLoS One

  8. HUANG CH, Wu LS, Jeng WJ, Cheng YF, et al
    In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival.
    PLoS One. 2019;14:e0212770.
    PubMed     Text format     Abstract available

  9. GREGORI J, Soria ME, Gallego I, Guerrero-Murillo M, et al
    Rare haplotype load as marker for lethal mutagenesis.
    PLoS One. 2018;13:e0204877.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  10. PETHE MA, Rubenstein AB, Khare SD
    Data-driven supervised learning of a viral protease specificity landscape from deep sequencing and molecular simulations.
    Proc Natl Acad Sci U S A. 2019;116:168-176.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: